$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Dosage and usage of monogravir capsules (molnupiravir)
2026-02-01 22:25:32
Check Details
Comparing molnupiravir capsules with Pfizer’s Paxlovid
2026-02-01 22:25:32
Check Details
Is molnupiravir capsules available in pharmacies?
2026-02-01 22:25:32
Check Details
Who is not suitable for monoravir capsules (molnupiravir)
2026-02-01 22:25:32
Check Details
Is molnupiravir a self-paid drug?
2026-02-01 22:25:32
Check Details
Why should I take molnupiravir capsules for 5 days?
2026-02-01 22:25:32
Check Details
Does molnupiravir pose a cancer risk?
2026-02-01 22:25:32
Check Details
What medicines cannot be taken with molnupiravir capsules?
2026-02-01 22:25:32
Check Details
Is molnupiravir effective in treating high fever due to lung infection?
2026-02-01 22:25:32
Check Details
Do I still need to take molnupiravir capsules if my symptoms turn negative after three days?
2026-02-01 22:25:32
Check Details
How effective is molnupiravir in treating COVID-19?
2026-02-01 22:25:32
Check Details
The role and efficacy of Neratinib
2026-02-01 22:25:32
Check Details
1
2
...
195
196
197
198
199
200
201
...
10209
10210
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
2
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis
3
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
4
Azacitidine Treatment Guide: Indications, Cross-Border Purchase & Safety Tips
5
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
6
A Precision FGFR Inhibitor for Cholangiocarcinoma
7
A Revolutionary Targeted Therapy for Hematological Malignancies
8
A New Option for Advanced Renal Cell Carcinoma Treatment
9
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
10
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
11
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
12
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide